Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Denosumab × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 22 Genitourinary 15 Plasma cell 9 Thoracic 3 Sarcoma 3 Head & Neck 3 Other solid neoplasm 2 Lymphoid 2 Gynecologic 2 Gastrointestinal 2 Endocrine 2 Dermatologic 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Myeloid 1

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

Cyclophosphamide 227 fludarabine phosphate 198 Azacitidine 162 fludarabine 159 Busulfan 145 Cytarabine 134 Imatinib Mesylate 129 Mycophenolic Acid 122 Whole-Body Irradiation 118 Tacrolimus 112 Peripheral Blood Stem Cell Transplantation 109 Melphalan 96 Cyclosporine 95 Antilymphocyte Serum 93 Decitabine 88 Filgrastim 87 Methotrexate 83 nilotinib 73 venetoclax 66 ruxolitinib 63 Stem Cell Transplantation 55 Granulocyte Colony-Stimulating Factor 55 Dasatinib 54 Radiotherapy 52 Thiotepa 51 thymoglobulin 50 Etoposide 43 Specimen Handling 42 Clofarabine 39 Methylprednisolone 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03401060 2024-05-03

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡